Explore more publications!

India Denounces Deadly Airstrike on Afghan Hospital

(MENAFN) India has strongly denounced the reported Pakistani airstrike on a hospital in Afghanistan that reportedly killed at least 400 people on Monday.

Pakistan has rejected responsibility, claiming its operations targeted only military facilities in Kabul and Nangahar province.

The strike hit Kabul’s 2,000-bed Omid Addiction Treatment Hospital at approximately 9 pm local time, according to Hamdullah Fitrat, the deputy spokesman for Afghanistan’s Taliban government, who reported the incident on X.

“India unequivocally condemns Pakistan’s barbaric airstrike on the Omid Addiction Treatment Hospital in Kabul on the night of March 16,” the Indian Foreign Ministry said in a statement.

“This is a cowardly and unconscionable act of violence that has claimed the lives of a large number of civilians in a facility which can by no means be justified as a military target.”

The statement further accused Pakistan of attempting to “dress up a massacre as a military operation,” labeling the incident as a “heinous act of aggression,” a “blatant assault on Afghanistan’s sovereignty,” and a direct “threat to regional peace and stability.”

The ministry emphasized that the attack occurred during the Muslim holy month of Ramadan, which made it “all the more reprehensible.”

MENAFN17032026000045017640ID1110871599


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions